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Experimental data indicates that soluble vascular endothelial growth factor (VEGF) receptor
1 (sFlt-1) modulates the guidance cues provided to sprouting blood vessels by VEGF-A. To
better delineate the role of sFlt-1 in VEGF signaling, we have developed an experimentally
based computational model. This model describes dynamic spatial transport of VEGF, and
its binding to receptors Flt-1 and Flk-1, in a mouse embryonic stem cell model of vessel
morphogenesis.The model represents the local environment of a single blood vessel. Our
simulations predict that blood vessel secretion of sFlt-1 and increased local sFlt-1 seques-
tration ofVEGF results in decreasedVEGF–Flk-1 levels on the sprout surface. In addition, the
model predicts that sFlt-1 secretion increases the relative gradient ofVEGF–Flk-1 along the
sprout surface, which could alter endothelial cell perception of directionality cues.We also
show that the proximity of neighboring sprouts may alter VEGF gradients, VEGF receptor
binding, and the directionality of sprout growth. As sprout distances decrease, the prob-
ability that the sprouts will move in divergent directions increases. This model is a useful
tool for determining how local sFlt-1 and VEGF gradients contribute to the spatial distri-
bution of VEGF receptor binding, and can be used in conjunction with experimental data
to explore how multi-cellular interactions and relationships between local growth factor
gradients drive angiogenesis.
Keywords: angiogenesis, vascular development, computational model,mathematical model, sFlt-1,VEGF, capillary
sprouting
INTRODUCTION
Angiogenesis is the growth of new blood vessels from an existing
vascular network. While it has been studied extensively in patho-
logical conditions such as cancer, angiogenesis is also essential for
organ development and recovery of tissues from injury. This com-
plex, multistep process is regulated, in part, by the extracellular
ligands of the vascular endothelial growth factor (VEGF) family.
VEGF ligands bind to and activate receptor tyrosine kinases on
the endothelial cell surface, initiating downstream signaling that
drives cellular behaviors such as proliferation and migration, cul-
minating in angiogenesis (Keck et al., 1989; Leung et al., 1989;
Olsson et al., 2006; Shibuya and Claesson-Welsh, 2006).
There are three known VEGF tyrosine kinase receptors:
VEGFR-1 (Flt-1 in mice),VEGFR-2 (Flk-1 in mice), andVEGFR-3
(Flt-4 in mice), and each receptor binds one or more members of
the VEGF ligand family to initiate different downstream signal-
ing pathways. In addition to the membrane-bound form of Flt-1
(mFlt-1), there is a soluble version of the receptor (sFlt-1) that
binds to and can sequester VEGF-A (VEGF) in the extracellular
space (Nilsson et al., 2010). Flt-1 and Flk-1 are both essential for
vascular development and viability, since genetic deletion of either
gene in mice causes death in utero (Fong et al., 1995; Shalaby et al.,
1995).
Vascular development is exquisitely sensitive to VEGF levels:
embryonic lethality results from knockout of a single VEGF allele
and from VEGF over-expression (Carmeliet et al., 1996; Ferrara
et al., 1996; Miquerol et al., 2000). While VEGF concentrations are
also important in angiogenesis for initiating new vessel sprouting,
the spatial distribution ofVEGF is an important regulator of blood
vessel branching morphogenesis (Carmeliet et al., 1999; Ruhrberg
et al., 2002; Stalmans et al., 2002). This has been demonstrated
experimentally through the effects of different VEGF isoforms
on vessel morphogenesis. These isoforms have varying heparin-
binding afﬁnities resulting in different local VEGF concentration
gradients that are perceived by endothelial cells of nascent vessels.
The endothelial cells in vessel sprouts sense VEGF gradients,
and they respond both by modifying their behavior and by
communicating with their neighbors in order to inﬂuence their
function. For example, Delta-like ligand 4 (Dll4) activates Notch
signaling in adjacent cells to repress sprouting (Hellstrom et al.,
2007), and Dll4 up-regulation is downstream of VEGF activation
(Lawson et al., 2002). Endothelial tip cells, which are at the front
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of the growing blood vessel sprout, extend ﬁlopodia and migrate
in response to VEGF gradients, whereas stalk cells, located behind
the tip cell of the sprout, proliferate in response to VEGF lev-
els (Gerhardt et al., 2003). Endothelial cells compete for the tip
cell position, and during sprouting, cells that have higher levels
of VEGF signaling are more likely to become tip cells (Jakobsson
et al., 2010).
Over the past decade, studies have revealed mechanisms
through which VEGF receptors modulate blood vessel forma-
tion. Flk-1 and mFlt-1 are monomeric VEGF receptors that have
cytoplasmic tyrosine kinase domains. VEGF is bivalent and ini-
tiates signaling by binding to two receptor monomers. The two
cytoplasmic receptor kinases in this complex phosphorylate each
other, thus initiating downstream signaling (Mac Gabhann and
Popel, 2008). If sFlt-1 replaces one of the receptors, then neither it
nor the other receptor is activated, as sFlt-1 lacks the cytoplasmic
kinase domain. In mouse embryonic development, Flt-1 and Flk-1
appear to compete forVEGF (Autiero et al., 2003). Flt-1modulates
the organization of embryonic vasculature (Fong et al., 1995); this
activity appears to be through VEGF sequestration and seems to
be independent of Flt-1 signaling (Hiratsuka et al., 1998). This
suggests that during development, Flt-1–Flk-1 heterodimers also
do not provide essential signaling. However, VEGF receptor het-
erodimers have been shown to exist and to be capable of signaling
(Huang et al., 2001; Nilsson et al., 2010), although their particular
role is still not clear. Similarly, analysis of ex vivo developmental
systems, such as embryonic stem (ES) cell cultures that undergo
differentiation to form primitive vessels, showed that elimina-
tion of all Flt-1 expression (both soluble and membrane-bound)
caused vascular overgrowth (Kearney et al., 2002, 2004). This phe-
notype was partially rescued by Flk-1 inhibitors (Kearney et al.,
2002; Roberts et al., 2004), exogenous Flt-1 (Roberts et al., 2004)
and re-expression of sFlt-1 (Zeng et al., 2007). While sFlt-1 and
mFlt-1 transgenes each partially rescued endothelial cell prolifer-
ation in ﬂt-1−/− mutant vessels, only the sFlt-1 transgene rescued
branching (Kappas et al., 2008). Furthermore, loss of Flt-1 activity
disrupted local sprout guidance in ES-cell-derived vessels, which
was partially rescued by sFlt-1 expression in endothelial cells in
the lateral base of the sprout (Chappell et al., 2009).
Several groups have used computational models to describe
processes involved in angiogenesis including endothelial cell
migration (Stokes et al., 1991), branching (Sun et al., 2005;
McDougall et al., 2006; Bauer et al., 2007), signaling (Levine et al.,
2002; Bentley et al., 2008) and VEGF transport and binding (Mac
Gabhann et al., 2006, 2007). Models of angiogenesis have been
extensively reviewed (Peirce, 2008; Qutub et al., 2009). The model
presented here focuses on how putative VEGF and sFlt-1 gradi-
ents affect vessel morphogenesis. Our previous studies regarding
VEGF transport include analysis of sFlt-1 (Wu et al., 2010a,b)
or receptor dimerization by VEGF (Mac Gabhann and Popel,
2007a), as well as simulations of 2- and 3-D VEGF diffusion gra-
dients (Mac Gabhann et al., 2006, 2007; Ji et al., 2007; Vempati
et al., 2010). However, this is the ﬁrst simulation of sFlt-1 gradi-
ents, and the ﬁrst simulation of sFlt-1 to include explicit receptor
dimerization.
Vascular endothelial growth factor secretion by parenchymal
cells and binding to VEGF receptors on endothelial cells (see
Figure 1) results in a VEGF gradient across the interstitial space.
Experiments have predicted that sFlt-1 is intimately involved in
endothelial sprouting processes; however, the existence of local
sFlt-1 gradients and their role near vessel sprouts has yet to be
measured or elucidated. sFlt-1 binds to VEGF, so it is possible that
sFlt-1 secretion reduces available VEGF. We simulated the impact
of opposing sFlt-1 and VEGF gradients on interstitial VEGF con-
centrations and distribution. In addition, the signaling of activated
Flk-1 receptors can be affected to different extents by sFlt-1 in
two ways: ﬁrst, sFlt-1 sequesters VEGF to decrease free ligand
concentrations available to bind cell surface receptors; second,
heterodimerization of sFlt-1 to Flk-1 permits the formation of
sFlt-1–VEGF–Flk-1 complexes, which are non-signaling but also
sequester and internalize VEGF. By simulating sFlt-1 and VEGF
transport and binding as well as receptor dimerization in a model
that represents the local sprout environment, we can quantify the
extent to which sFlt-1 sequestration vs. sFlt-1–(mFlt-1/Flk-1) het-
erodimerization affect Flk-1 activation. The model outputs the
level and distribution of activated Flk-1 across the cell surface, and
we interpret these as metrics for pro-angiogenic signaling.
To quantify the extent to which sFlt-1 alters VEGF signaling,
we have developed an experimentally based computational model
describing dynamic spatial transport of VEGF and its receptors
in the mouse ES-cell culture system. Brieﬂy, in the experiments
simulated by our computational model, ES-cells undergo a pro-
grammed differentiation to produce multiple cell types including
vascular endothelial cells, which give rise to primitive blood ves-
sels via angiogenic sprouting in a context similar to the developing
embryo and yolk sac (Zeng and Bautch, 2009). Our computa-
tional model system represents the local environment of a blood
vessel sprout and nearby mesendoderm tissue at the leading edge
of developing blood vessel networks. In the model, cell positions
are static, but we simulate dynamic VEGF and sFlt-1 transport
and binding. Our simulations suggest that sFlt-1 sequestration of
VEGF in the interstitial space signiﬁcantly altersVEGF–Flk-1 levels
on the cell surface, thus inﬂuencing directionality of future sprout
growth. We also predict that the proximity of neighboring sprouts
to one another may alter local VEGF gradients, VEGF receptor
binding, and the directionality of sprout growth.
MATERIALS AND METHODS
SIMULATION ENVIRONMENT
We present a computational model that represents the local envi-
ronment of a single blood vessel within a biological system with
several cell types and a source of VEGF. The environment has the
dimensions 210μm× 200μm× 10μm(Figure 1A), and includes
endothelial cells and parenchymal cells (source of VEGF), which
are separated by interstitial space (see Figure 1 in Chappell et al.,
2009 for images of ES-cell-derived vessels). In ourmodel, the inter-
stitial space is ﬁlledwith extracellularmatrix (ECM).This is treated
as a homogenous matrix, representing the amalgamation of var-
ious proteins that are present in the microenvironment; in the
future, we will expand the model to include other cell types in this
space. In this model, cells do not move (their position is static) or
proliferate, but parenchymal cells dynamically secrete VEGF, and
endothelial cells dynamically bind VEGF, secrete sFlt-1 and inter-
nalize mFlt-1 and Flk-1. There are a number of splice variants of
mouse (and human) VEGF-A; in this study, we have modeled the
most common isoform,VEGF164 (hereafter referred to as VEGF).
Frontiers in Physiology | Computational Physiology and Medicine October 2011 | Volume 2 | Article 62 | 2
Hashambhoy et al. Soluble VEGF receptor gradients
FIGURE 1 | Schematics. (A,B) Schematics of the 2-D computational model
space. In (A), sFlt-1 is secreted from an opposing wall of parenchymal cells. In
(B), sFlt-1 is secreted from a layer of parenchymal cells below the interstitial
space. Diffusion in the z direction is assumed to be instantaneous, and both
cases (A,B) are essentially 2-D models. (C) Schematic of the molecular
species and the cell surface signaling and non-signaling receptor complexes.
(D) Schematic showing non-signaling (top) and signaling (bottom) receptor
complexes.
This splice variant has the ability to reversibly bind to ECM and to
cell surface receptors.
Figure 1A illustrates the conﬁguration that was simulated to
explore the gradients that are shown in Figure 2. At the ini-
tiation of the simulation, a sprout has emerged from the base
vessel. The base vessel is composed of multiple endothelial cells.
The sprout protrudes out of the middle of the base, with dimen-
sions 10μm× 20μm, which are consistent with experimentally
observed values (Kearney et al., 2004; Chappell et al., 2009). A line
of parenchymal cells 200μm from the base vessel secretes VEGF
into the interstitial space. Figures 3–5 show results from simula-
tions in which VEGF is secreted by parenchymal cells below the
ECM (as represented in the schematic in Figure 1B). In all sim-
ulations, endothelial cells are capable of secreting sFlt-1 into the
interstitial space. In ES-cell cultures, day 3 embryoid bodies are
seeded so that upon differentiation (day 8) they cover the bottom
of a 24-well dish (Kearney and Bautch, 2003). The simulation area
is∼0.02% of the area of one of these wells.
The reaction–diffusion equations on which this model is based
are similar to those that have been published previously (Mac
Gabhann et al., 2006; Mac Gabhann and Popel, 2007a; Wu et al.,
2010b). The model includes a number of physiological processes
involved in sprout development, including:VEGF and sFlt-1 secre-
tion by parenchymal and endothelial cells, respectively; VEGF and
sFlt-1 diffusion,degradation and binding to ECM in the interstitial
space; VEGF binding to sFlt-1 and surface receptors mFlt-1 and
Flk-1; dimerization of sFlt-1,mFlt-1, and Flk-1 byVEGF; insertion
of mFlt-1 and Flk-1 in the endothelial cell membrane; and inter-
nalization and degradation of receptors. Table 1 lists the kinetic
parameters of the system.
DIFFUSION
Vascular endothelial growth factor, sFlt-1 and the VEGF–sFlt-1
complexes diffuse through the interstitial space. These species
degrade at constant rates, and bind to other volumetric as well as
membrane-bound species. Diffusion in the z direction is assumed
to be very fast, and therefore is not explicitly modeled, however
we include a deﬁned thickness to allow a non-zero sprout edge
surface area for binding and secretion. The top surface of cells is
not considered in this model. An example of a reaction–diffusion
equation is shown below (for VEGF):
∂V
∂t
= DV
(
∂2V
∂x2
+ ∂
2V
∂y2
)
+ qV − kdeg(V ) + RxV
where V is the concentration of VEGF; DV is the diffusivity of
VEGF; q is the secretion rate; kdeg is the degradation rate; and
RxV refers to binding/unbinding reactions for VEGF. The model
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FIGURE 2 |Volumetric Gradients ofVEGF and sFlt-1. (A–D) Gradients
of VEGF, sFlt-1, and their complexes along a line from the sprout leading
edge to the parenchymal cell wall. (E–H) Gradients of VEGF, sFlt-1, and
their complexes along a transverse line in front of the sprout leading
edge. (B,F) VEGF gradients in the absence (dotted line) and presence
(solid line) of sFlt-1 (C,G), sFlt-1 (red) and VEGF–sFlt-1 complex (purple)
gradients, (D,H), ECM-bound gradients: ECM–VEGF in the absence
(dotted blue line) and presence (solid blue line) of sFlt-1 and
ECM–VEGF–sFlt-1 (purple line). All results are from 10h after the start of
simulation.
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does not allow for degradation of ECM-bound complexes. The
diffusivity constants for sFlt-1 and VEGF-bound sFlt-1 complexes
were calculated by using the ratios of molecular weights between
these molecules and VEGF and the calculated diffusivity of VEGF
(Vempati et al., 2010).
BINDING
The reaction term (Rx) includes ligand binding to soluble recep-
tors, cell surface receptors, and glycoprotein sites in theECM,along
with the dimerization of receptors (Figure 1B). For example, for
VEGF:
RxV = −kon(V ,S)[V ][s] + koff(V ,S)[V · s] − kon(V ,E)[V ][E]
+ koff(V ,E)[V · E]
− kon(V ,m)[V ][m] + koff(V ,m)[V · m] − kon(V ,F)[V ][F ]
+ koff(V ,F)[V · F ]
− 2kon(V ,m)[V ][m · m] + koff(V ,m)[V · m · m]
− kon(V ,m)[V ][m · F ] + koff(V ,m)[V · m · F ]
− kon(V ,F)[V ][m · F ] + koff(V ,F)[V · F · m]
− 2kon(V ,F)[V ][F · F ] + koff(V ,F)[V · F · F ]
− kon(V ,s)[V ][s · F ] + koff(V ,s)[V · s · F ]
− kon(V ,F)[V ][s · F ] + koff(V ,F)[V · F · s]
− kon(V ,s)[V ][s · m] + koff(V ,s)[V · s · m]
− kon(V ,m)[V ][s · m] + koff(V ,m)[V · m · s]
where E is ECM, s is sFlt-1, m is mFlt-1, and F is Flk-1; kon and
koff are the kinetic rates of binding and unbinding, respectively.
FormFlt-1 andFlk-1,which are anchored to the cellmembrane,
we do not include diffusion along the cell surface, and thus cell sur-
face molecule concentrations are calculated using equations of the
general form:
∂R
∂t
= sR − kint(R) + RxR
where sR is the insertion rate of new receptors into the mem-
brane, k int is the internalization and Rx includes ligand binding
and receptor dimerization reactions. The values of the binding
afﬁnities and kinetic rates are similar to our previous models
(Mac Gabhann and Popel, 2007a; Wu et al., 2010b), and derived
from empirical data. This assumes that kinetic parameters, such as
binding and unbinding rates, are similar among different experi-
mental systems, e.g., in vitro cell culture and endothelial cells in
developing vasculature. sFlt-1–VEGF binding and dimerization
parameters were constrained to produce observed Kd values for
VEGF–sFlt-1 binding close to those that were measured assuming
1:1 binding (Tanaka et al., 1997). We assumed that the afﬁnity
of sFlt-1 dimerization with mFlt-1 was similar to that of VEGF
binding mFlt-1. We also assumed that sFlt-1 andVEGF bind ECM
with the same afﬁnity, since both proteins have heparin-binding
properties (Park and Lee, 1999; Wu et al., 2010b). We did not
include binding between cell surface receptors and ECM-bound
ligands. Surface edges have a thickness of 10μm, corresponding
to the thickness of the simulation environment. Endothelial cells
expressmembrane-bound receptorsmFlt-1 andFlk-1 on their sur-
faces at a density of 6.64× 10−6 nmol/cm2 or 40 receptors/μm2,
which is consistent with expression levels in our previous models
(Mac Gabhann and Popel, 2007a). In the model, sFlt-1 can also
heterodimerize with Flk-1; determining the extent to which sFlt-
1–Flk-1 binding has an effect on Flk-1 signaling was a secondary
goal of this study.
LIGAND SECRETION
Vascular endothelial growth factor secretion was constrained in
order for simulation mean concentrations in the tissue to match
steady state interstitial concentrations in previous models (Wu
et al., 2010b). Kappas et al. (2008) observed that in ES-cell-derived
vessels, the relative proportions of sFlt-1 and mFlt-1 RNA levels
are roughly equal. Therefore, in the model, the sFlt-1 secretion
rate was ﬁxed so that it matched the mFlt-1 production rate. Each
cell has a ﬁxed secretion rate, and the amount of VEGF or sFlt-
1 secreted from a patch of the cell’s membrane is a function of
the cell’s secretion rate and the surface area of the patch that is
exposed to interstitial space. Following secretion, the ligands dif-
fuse through the ECM and form a concentration gradient driven
by degradation and receptor binding (Mac Gabhann et al., 2006,
2007; Ji et al., 2007; Vempati et al., 2010).
MODEL SIMULATION
The simulation space is divided into a 2-D 43× 41 grid, and par-
tial differential equations are solved using the central difference
method in space and the forward difference method in time. An
odd number of grid points allows us to place the sprout symmet-
rically. The grid size was chosen to be smaller than the cells size
so that receptor activation could be visualized across the surface
of each cell. Each grid size represents 5μm. A no-ﬂux boundary
condition is used at the edges of the grid. At the start of each sim-
ulation, it is assumed that there is an average of 1 pM of freeVEGF,
1 nM of ECM, and 100 pM of ECM-boundVEGF in the interstitial
space. The simulations were coded and run using Fortran.
RESULTS
sFlt-1 SECRETION LOWERS AVAILABLE VEGF CONCENTRATION
Figure 2 shows the predicted gradients of soluble VEGF, sFlt-1,
VEGF–sFlt-1, and ECM-bound VEGF complexes along straight
lines across the interstitial space (dashed lines in Figures 2A,E)
after 10 h of sFlt-1 secretion. FreeVEGF concentrations are higher
in the absence of endothelial cell sFlt-1 secretion (compare solid
(+sFlt) vs. dashed (−sFlt) lines in Figures 2B,F).
We quantiﬁed the relative gradients over the straight line across
the interstitial space (dashed line in Figure 2A). The gradient was
calculated by dividing the difference between the maximum and
minimum concentration by the concentration at the midpoint,
and normalizing to 20μm, the typical length of a tip cell. In the
presence of sFlt-1 secretion, free VEGF ranges from 1.7 pM at the
sprout leading edge to 6.1 pM at the parenchymal cell wall (an
average gradient of 17.0% per 20μm). In the absence of sFlt-1
secretion, the concentration ranges from11 to 20.8 pM (an average
gradient of 7.9% per 20μm). ECM-bound VEGF concentrations
display relative gradients similar to those of free VEGF over the
length of the sprout in the presence or absence of sFlt-1 (16.2 and
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FIGURE 3 | sFlt-1 can alter both absolute and relative levels of active
Flk-1 on the sprout. (A–C) local VEGF and sFlt-1 gradients near the sprout for
the scenario with sFlt-1 secretion from both the base vessel and the sprout.
Note that the y -axis is stretched compared to the x -axis to emphasize the
area local to the sprout. See the text and Figure 2 for more on the gradients
in the x - and y -directions. (D) Active distribution across the endothelial
surface. Flk-1 is considered active if both subunits in a dimerized Flk-1
complex are bound to VEGF. The results of three different scenarios are
displayed: no sFlt-1 secretion from the sprout; sFlt-1 secretion only from the
endothelial cells making up the base vessel; sFlt-1 secretion from both vessel
and sprout. sFlt-1 secretion decreases the absolute amount and relative
gradient of Flk-1 activation on the surface of sprouts. (E) As free sFlt-1
increases (due to increased sFlt-1 secretion) so does relative Flk-1 activation
along the sprout. (F) Average receptor complex concentrations along the
sprout for three cases: no sFlt-1 secretion (red), base and sprout sFlt-1
secretion (black), and base and sprout sFlt-1 secretion without any sFlt-1
binding to surface receptors mFlt-1 or Flk-1 (green). Active VEGF surface
complexes are shown on the left, and inactive surface complexes are on the
right. The removal of sFlt-1 heterodimerization barely affects active VEGF
surface receptor complex levels.
8.0%, respectively). Free sFlt-1 concentrations range from 54 to
91 pM (an average gradient of 7.3% per 20μm). ECM-bound sFlt
ranges from 2.24 to 3.81 nM, a gradient of 7.3% along the length
of the sprout.
Local VEGF gradients are close to constant across the inter-
stitial space, ranging from 18.6% near the sprout to 17.0% near
the parenchymal cells. In contrast, the local sFlt-1 gradients are
much steeper closer to the sprout (10.4% per 20μm) than near
the parenchymal cells (2.3% per 20μm).
Note that the total amount of sFlt-1 in the interstitial space
is over 100-fold higher than the total amount of mFlt-1 on the
vessels; this is in broad agreement with placental data showing a
50-fold excess of sFlt-1 protein (Carmeliet et al., 2001), and occurs
despite the 50:50 ratio of sFlt-1 and mFlt-1 expression, primarily
due to sFlt-1 binding to ECM.
When endothelial cells secrete sFlt-1, sFlt-1 is highest where
VEGF is lowest – near the endothelial cells (Figures 2C,G,
red lines). Free sFlt-1 binds and forms complexes with VEGF
(Figures 2C,G, purple lines), thus reducing the concentration
of free VEGF available for receptor binding. Perhaps more sig-
niﬁcantly, ECM-bound sFlt-1 binds VEGF (Figures 2D,H, pur-
ple lines), which reduces free VEGF degradation and increases
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FIGURE 4 | Decreased tip cell sFlt-1 secretion results in
increased Flk-1 activation on the sprout. (A,B) Active Flk-1 levels
on 10μm long (A) or 30μm long (B) sprouts in which tip cell sFlt-1
secretion is the same or lower than that of base vessel cells. The
difference in Flk-1 activation on the leading edge of the sprout (due
to decreased sFlt-1 secretion) compared to Flk-1 activation on the
base vessel is more pronounced in short sprouts than in longer
sprouts.
total VEGF levels in the interstitial space. However, the sFlt-1
sequestration of VEGF is high enough that free VEGF and
ECM-bound VEGF levels are reduced.
sFlt-1 SECRETION ALTERS ABSOLUTE AND RELATIVE Flk-1 ACTIVATION
ON SPROUT SURFACES
We investigated the hypothesis that sFlt-1 sequesters VEGF,
altering VEGF gradients, and inﬂuencing sprout morphogenesis
(Chappell et al., 2009). It is well established that VEGF signaling
through Flk-1 leads to cell proliferation and migration (Wal-
tenberger et al., 1994;Gerber et al., 1998). Based onVEGF isoform-
speciﬁc experiments in mouse embryos (Ruhrberg et al., 2002), it
is hypothesized that endothelial cells proliferate in response to
the perceived VEGF concentration, and they sprout and migrate
in response to gradients of VEGF. Therefore in analyzing the
simulation results, we present both the amount and the spatial
organization of VEGF-activated Flk-1 as indicators of the strength
of VEGF-induced cell signaling. In this set of simulations, VEGF
is secreted by a layer of parenchymal cells below the ECM (as
shown in Figure 1B). This scenario more closely mimics the
sprouting environment in ES-cell cultures, since the underlying
endoderm is the primary source of VEGF ligand (Bautch et al.,
2000). Figures 3A–C show local freeVEGF, sFlt-1, andVEGF–sFlt-
1 levels around the sprout. In the previous set of simulations, the
absence of sFlt-1 allows more free VEGF to be available for mem-
brane receptor binding and activation (Figures 2B,F). Therefore
we predict that there is increased active Flk-1 over the entire sprout
surface, and simulations conﬁrm that this is the case (Figure 3D).
Chappell et al. (2009) observed that in ES-cell-derived vessels,
the ﬂt-1 gene is more highly activated in base vessel cells, just
lateral to the sprout, than in sprout cells. In our simulations, all
the endothelial cells of the base vessel secrete sFlt-1, and the soluble
receptor binds to VEGF, thus reducing the amount of free VEGF
available for Flk-1 binding, which results in decreased active Flk-1
levels. Active Flk-1 concentration is reduced further when both
the base and the nascent sprout secrete sFlt-1 (Figure 3D).
Plots of the spatial distribution of active Flk-1 along the sprout
surface at different scales (Figure 3D) suggest that sFlt-1 secretion
alters the absolute levels of Flk-1 activation, but it does not alter
the surface pattern of active Flk-1. That is, the highest activation is
always at the leading edge of the tip cell, and the lowest active Flk-1
levels are at the base of the sprout. Relative active Flk-1 gradients
are calculated as the difference between the average active Flk-1
values on the leading and trailing edges, divided by the active Flk-
1 midway along the cell. The relative activation proﬁle of Flk-1 on
the sprout is affected by sFlt-1 secretion. The active Flk-1 gradi-
ent along the sprout is 14.6% when there is sFlt-1 secretion from
the base and the sprout compared to 13.4% when there is sFlt-1
secretion only from the base and 9.1% when there is no sFlt-1
secretion. These differences in the distribution of Flk-1 activation
are similar to the change in interstitial VEGF gradients. Higher
Flk-1 activation gradients accompanied lower absolute active Flk-
1 levels, suggesting that small changes in activation could magnify
the relative difference along the sprout. Simulations predict that
when sFlt-1 secretion (and therefore free sFlt-1 level) is increased,
the active Flk-1 gradient increases as well (Figure 3E).
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FIGURE 5 | Active Flk-1 levels show that sprout directionality is
partially governed by proximity to neighboring sprouts. All
panels are for the scenario with both base and sprout sFlt-1
secretion. (A,B) Active Flk-1 levels on sprouts that are closer to (A)
or farther away from (B) each other. (C) Free VEGF and (D), free
sFlt-1 in the vicinity of the pair of sprouts that are close together. (E)
Free VEGF and (F), free sFlt-1 in the vicinity of the pair of sprouts
that are farther apart. Note that for panels (C–F), the y -axis is
stretched compared to the x -axis, and the geometry of the sprouts
is outlined on the x–y plane.
Figure 3F illustrates the average magnitude of VEGF-bound
receptors on the sprout for three scenarios: no sFlt-1 secretion
(red), base and sprout sFlt-1 secretion (black), and base and
sprout sFlt-1 secretion in the absence of sFlt-1 heterodimeriza-
tion (green). In the base and sprout secretion case (black points),
the number of inactiveVEGF-bound sFlt-1 heterodimers is on the
same order of magnitude as the active VEGF-bound membrane
receptors. Based on these results alone, we would predict that sFlt-
1 binding to mFlt-1 and Flk-1 might have a large inﬂuence on
Flk-1 andmFlt-1 activation.However, calculations show that there
is 2.8× 10−10 nmol of VEGF-bound sFlt-1 that is unbound to the
vessel, compared to 8.3× 10−14 that is bound to mFlt-1 or Flk-
1; simulations in the absence of sFlt-1 heterodimerization (green
points) show that binding of sFlt-1 to membrane receptors has
very little effect on absolute receptor activation. In addition, the
Flk-1 gradient is only affected by a small amount (it decreases from
15.5% with heterodimerization to 14.5% without dimerization,
data not shown). Therefore, it appears that sFlt-1 sequestration
of VEGF away from the vessel surface has a larger effect on Flk-1
activation than sFlt-1 heterodimerization with surface receptors.
In addition, we investigated the possible role that sprout length
plays in sFlt-1 modulation of Flk-1 activation (Figure 4). We sim-
ulated shorter sprouts (protruding out of the base by 10μm),
and longer sprouts (protruding out of the base by 30μm). The
active Flk-1 gradient along the (10μm long) side of the tip cell
increases with sprout length. The active Flk-1 gradient along the
tip cell on the short sprout is 7.2%, on the medium (20μm long)
sprout it is 8.8%, and on the long sprout it is 9.0%. Jakobsson
et al. (2010) showed that cells with lower Flt-1 expression domi-
nate the tip cell position. Therefore, for the short and long sprout
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Table 1 | Kinetic parameters of theVEGF system.
Value Reference
Diffusivity (cm2/s)
VEGF 6.88×10−7 Vempati et al. (2010)
sFlt 5.07×10−7 See text
VEGF–sFlt 4.52×10−7 See text
sFlt–VEGF–sFlt 4.14×10−7 See text
VEGF binding to mFlt
kon (nM−1 s−1) 2.2×10−2 Mac Gabhann and Popel (2007a)
koff (s−1) 2.6×10−2 Mac Gabhann and Popel (2007a)
VEGF binding to Flk-1
kon (nM−1 s−1) 4.4×10−3 Mac Gabhann and Popel (2007a)
koff (s−1) 2.6×10−2 Mac Gabhann and Popel (2007a)
VEGF binding to sFlt-1
kon (nM−1 s−1) 5.5×10−1 See text
koff (s−1) 2.6×10−2 See text
VEGF binding to ECM
kon (nM−1 s−1) 4.2×10−4 Wu et al. (2010b)
koff (s−1) 1.0×10−2 Wu et al. (2010b)
sFlt-1 binding to ECM
kon (nM−1 s−1) 4.2×10−4 Wu et al. (2010b)
koff (s−1) 1.0×10−2 Wu et al. (2010b)
sFlt-1 binding to mFlt
kon (nM−1 s−1) 2.2×10−2 See text
koff (s−1) 1.0×10−2 See text
sFlt-1 binding to Flk-1
kon (nM−1 s−1) 2.2×10−2 See text
koff (s−1) 1.0×10−2 See text
Coupling rate of bound membrane receptors (cm2 nmol−1 s−1) 2.1×105 Mac Gabhann and Popel (2007a)
Coupling rate of empty receptors (cm2 nmol−1 s−1) 105 Mac Gabhann and Popel (2007a)
Rate of receptor binding second receptor in ternary complex (s−1) 0.446 Mac Gabhann and Popel (2007a)
Rate of VEGF binding second receptor in ternary complex (s−1) 0.949 Mac Gabhann and Popel (2007a)
Dissociation rate of empty receptors (s−1) 10−2 Mac Gabhann and Popel (2007a)
Degradation of volumetric species (s−1) 10−4 Derived from Storkebaum et al. (2005)
Surface receptor internalization and insertion rate (s−1) 2.8×10−4 Wu et al. (2010b)
VEGF secretion rate (nmol cm−2 s−1; Figure 2) 5.0×10−10 See text
VEGF secretion rate (nmol cm−2 s−1; Figures 3–5) 2.8×10−11 See text
sFlt secretion rate (nmol cm−2 s−1) 1.86×10−9 See text
Tip cell sFlt-1 secretion rate (nmol cm−2 s−1; Figure 5) 1.86×10−10 See text
cases, we also included a scenario in which tip cell sFlt-1 secretion
is an order of magnitude lower than base vessel sFlt-1 secretion.
With lower tip cell secretion, average active Flk-1 levels on the
tip cell increase by 19% from 0.32 to 0.38 pmol/m2 (shown in
Figure 4A) for the short sprout and these active receptor levels
are higher than those on the cells near the base of the sprout, sug-
gesting that the leading edge of the growing sprout is the most
active local site of VEGFR signaling. When tip cell secretion is
the same as that of the base vessel, Flk-1 activation on base ves-
sel cells 50μm away from the sprout is at similar levels to the tip
of the sprout, suggesting that new sprouts may form near to the
existing sprout. Thus, sFlt-1 expression modulation in the tip cell
may aid in nearby sprout repression. When we simulated longer
sprouts with lower tip cell secretion, average Flk-1 levels on the
tip cell increased by 17% from 0.27 to 0.32 pmol/m2 (shown in
Figure 4B). However, Flk-1 activation on the nearby endothelial
cells along the base vessel does not reach the same levels as that
on the tip of the sprout, even when sFlt-1 secretion by the tip
cell is reduced, which suggests that longer sprouts may repress
nearby sprouting regardless of sFlt-1 modulation. These results
indicate that reduced tip cell sFlt-1 secretion may play a role in
determining the location from which a sprout emerges from a
parent vessel, and is most critical at the very early stage of sprout
development.
NEARBY SPROUTS INFLUENCE PERCEIVED VEGF GRADIENT
The correct assembly of vessels into a functional vascular network
requires that new vessels have cues for correct patterning. Just
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as the Dll4-Notch system prevents over-sprouting, new sprouts
grow preferentially perpendicular to the base vessel, apparently in
response to sFlt-mediated cues. We simulated a pair of sprouts
protruding from the same vessel, and determined the effects they
had on each other via their sFlt-1 production as a function of the
distance between them. In this set of simulations, the vessel base
and sprouts secrete sFlt-1 into the interstitial space.
Figures 5A,B illustrate the distribution of activated Flk-1 on
cell surfaces after 10 h of sFlt-1 secretion from the base vessel
and sprouts. When the sprouts are closest to each other (10μm
apart, Figure 5A), activated Flk-1 levels are highest (dark orange)
at the corners of the sprout tip that are furthest away from the
neighboring sprout. Active Flk-1 levels are lowest on the cell sur-
faces of the vessel base between the sprouts. If active Flk-1 is a
predictor of cell proliferation and/or migration, this result sug-
gests that sprouts that are in close proximity tend to diverge. This
may prevent the formation of sprout anastamoses too close to
the parent vessel. However, when sprouts develop further apart
(150μm, Figure 5B), active Flk-1 levels are more uniform along
the tip cells, indicating a lack of lateral directional cues; therefore,
simulation results suggest that they are likely to migrate straight
ahead. When sprouts are close together, free VEGF is higher near
the outside edges of the sprouts (Figure 5C), while free sFlt-1
is highest in the space between the sprouts (Figure 5D), where
it sequesters VEGF. These ﬁndings suggest that sequestration of
VEGF by sFlt-1 results in local activated Flk-1 relative distribution
patterns that inﬂuence directionality. Note, in particular, that the
concentration of activated Flk-1 between the two close sprouts
is signiﬁcantly lower than the concentration on the other side of
the endothelial cells (Figure 5A). These simulation results lead us
to predict that, based on active Flk-1 proﬁles, nearby sprouts will
tend to diverge. Interestingly, the simulation predicts that when
sFlt-1 secretion is absent, sprouts display qualitatively similar acti-
vated Flk-1 proﬁles as those shown in Figure 5A (data not shown).
However, the results differ quantitatively when sFlt-1 secretion is
present. Namely, with the addition of sFlt-1 secretion, Flk-1 acti-
vation is 40% higher at the leading outside edge of the sprout
compared to the inside edge, whereas in the absence of sFlt-1,
this increase is only 26%. These predictions suggest that VEGF
sequestration by sFlt-1 magniﬁes the lateral cues for sprout diver-
gence that result from spatial barriers to diffusion caused by the
endothelial cells.
DISCUSSION AND CONCLUSION
Studies in differentiated ES-cell cultures have shown that ﬂt-1−/−
ES-cell-derived blood vessels display signiﬁcant dysmorphogen-
esis (Kearney et al., 2002, 2004). Vessel branching is perturbed,
and ﬂt-1 mutant endothelial cells proliferate more than their
wild-type counterparts. These properties are partially rescued by
expression of a sFlt-1 transgene (Kappas et al., 2008). To quantify
the extent to which sFlt-1 alters VEGF signaling in a biological
context, we have developed an experimentally based computa-
tional model describing dynamic spatial transport of VEGF and
its receptors, based on blood vessel morphogenesis during mouse
ES-cell differentiation. One of the goals of this study is to use
this model to further understand how sFlt-1 modulates vessel
morphogenesis.
Simulation predictions indicate that sFlt-1 sequesters enough
VEGF as to reduce free VEGF in the interstitial space (Figure 2)
and to decrease active Flk-1 levels on the endothelial cell sur-
face (Figure 3). Since Flk-1 activation promotes endothelial cell
division and migration, our results suggest that sFlt-1 reduces
the probability of proliferation along the whole vessel. This is
in agreement with the observations of Kappas et al. (2008), that
sFlt-1 partially rescues the increased mitotic index displayed by
ﬂt-1−/− cells. The simulations also predict that sFlt-1 decreases
absolute active Flk-1 and creates differences in relative spatial
distribution of Flk-1 activation (Figure 3) and that it does so
primarily through sequestration of VEGF in the ECM (rather
than through heterodimerization of receptors). This supports
the hypothesis of Chappell et al. (2009) that sFlt-1 seques-
tration of VEGF increases relative VEGF gradients around the
sprout, which results in guidance cues and rescue of vessel
dysmorphogenesis.
There is an experimentally observed link between sprout prox-
imity and sprout angle in ﬂt-1−/− ES-cell cultures (Chappell et al.,
2009). Compared to wild-type cells, sprouts from ﬂt-1−/− ES-cell-
derived vessels develop closer to each other, and grow at angles
more acute to the base vessel. While our simulations are sta-
tic and not dynamic, the results suggest that sprout proximity
may be a contributory factor to the morphological outcome of
sprouting vessels. The model results suggest that, as the distance
between sprouts decreases, lateral directionality cues becomemore
pronounced, possibly to prevent early anastamoses (too close to
the base vessel). This is only part of the story, however, as sFlt-1
clearly inﬂuences sprout angle independent of sprout proximity
(Chappell et al., 2009).
One of the inherent limitations of the model is that it does
not represent the 3-D nature of the experimental system. Thus, it
cannot account for diffusion above or below cells. However, even
when we simulateVEGF secretion from cells below the surface, we
see that there is a diffusion barrier created by nearby sprouts that
drives lateral directionality cues. These cues are magniﬁed in the
presence of sFlt-1 secretion. This may explain why sFlt-1 rescues
vessel dysmorphogenesis experimentally (Chappell et al., 2009).
We are developingmodels to incorporate 3-D cell and tissue geom-
etry. Themodel currently represents the environment surrounding
blood vessels in a static system (i.e., cells do not migrate or pro-
liferate). To dynamically simulate growing sprouts, which would
permit the emergence of non-perpendicular vessels and other fea-
tures, we plan to incorporate an agent-based model (Peirce et al.,
2004; Bailey et al., 2007, 2009; Robertson et al., 2007). The model
does not include neuropilin-1, amembrane-bound receptor found
on the surface of endothelial cells. Neuropilin-1 binds to mFlt-1,
Flk-1, andVEGF, thus affecting the distribution of activatedVEGF
receptors (Mac Gabhann and Popel, 2005, 2007b). We will include
this receptor in future simulations.Weare alsoworkingondecreas-
ing the computational time required for the simulations, which
would allow us to perform more detailed parameter sensitivity
analyses and further investigate how different sprout conﬁgura-
tions, secretion rates, andVEGF and sFlt-1 gradients contribute to
vessel morphogenesis.
The multi-scale model we have introduced allows us to isolate
at high resolution how sFlt-1 and VEGF modulate guidance cues
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and direct sprout growth. It has been constrained by kinetic data,
and supports sprout morphogenesis observations in ES-cell cul-
ture systems. It is a useful tool that can be used as a foundation
upon which to explore multi-scale interactions and relation-
ships between local growth factor gradients driving angiogenesis
behaviors in this unique experimental model.
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